cyc 202 has been researched along with ovalbumin in 2 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 19,565 | 63 | 5,664 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chilvers, ER; Condliffe, AM; Cowburn, AS; Farahi, N; Farrow, SN; Foster, MR; Gibson, A; Juss, JK; Langton, AJ; Marco-Casanova, P; Sobolewski, A; Uller, L | 1 |
| Duan, J; Hall, M; Leskov, KS; Liu, Q; Rosenbaum, JT; Wu, X; Zhang, GL; Zhang, Z | 1 |
2 other study(ies) available for cyc 202 and ovalbumin
| Article | Year |
|---|---|
Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance.
Topics: Animals; Apoptosis; Cell Survival; Cells, Cultured; Cyclin-Dependent Kinases; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Female; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Ovalbumin; Protein Kinase Inhibitors; Purines; Roscovitine; Time Factors | 2011 |
Roscovitine suppresses CD4+ T cells and T cell-mediated experimental uveitis.
Topics: Animals; Antibodies; Autoimmune Diseases; CD28 Antigens; CD3 Complex; CD4-Positive T-Lymphocytes; Cell Proliferation; Cyclin-Dependent Kinase 2; G1 Phase; Gene Expression; Hyaluronan Receptors; Immunologic Factors; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ovalbumin; Protein Kinase Inhibitors; Purines; Receptors, OX40; Roscovitine; S Phase; Uveitis | 2013 |